Jubilant Ingrevia cash flow

Latest FY26

Cash from operations: ₹524cr+3.2% on FY25
Capital spending: ₹299cr−18.2% on FY25
Free cash flow: ₹225cr+58.0% on FY25
Cash from financing: −₹155cr−₹129 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	175	158	136	122
	—	49.1	55.6	52.7	21.6
	—	−1.5	−2.9	−1.0	−1.2
	—	10.7	12.1	6.7	2.7
	—	8.3	−1.8	0.6	1.2
	—	1.0	0.5	6.4	1.4
	—	0.0	0.0	0.0	−0.1
	—	−0.2	0.0	1.0	0.5
	—	65.0	−2.1	93.0	−126
	—	−168	−36.8	−62.1	0.0
	—	0.0	0.0	0.0	114
	—	0.0	0.0	7.1	0.0
	—	−8.1	−0.7	0.0	0.0
	—	107	48.6	−34.5	−33.3
	—	17.8	0.0	0.0	0.0
	—	0.0	13.7	2.3	0.0
	—	0.8	0.0	0.0	0.0
Cash from operating activities
	466	370	344	268	437
	—	258	244	208	103
	—	628	588	476	540
	—	103	79.6	46.0	77.4
	—	524	508	430	462
Cash from investing activities
	—	299	366	568	481
	—	9.8	13.6	2.2	0.0
	—	0.0	0.0	0.0	3.2
	—	13.5	10.3	2.7	2.1
	—	11.3	0.0	0.0	0.0
	—	0.9	3.2	0.7	1.1
	—	37.5	−33.6	−0.7	7.3
	—	−276	−393	−569	−472
Cash from financing activities
	—	2.1	4.4	0.0	0.0
	—	32.2	0.0	0.0	0.0
	—	110	48.0	336	268
	—	89.4	24.4	0.0	100
	—	3.6	3.3	2.7	2.8
	—	63.1	73.6	67.9	44.0
	—	79.3	79.8	78.6	79.3
	—	0.0	0.0	−42.9	0.0
	—	−155	−129	144	41.6
	—	92.9	−13.5	5.3	32.2
	—	26.2	4.1	0.7	3.0
	—	119	−9.4	6.1	35.1
	—	—	69.4	78.8	72.7
Reference items
	701	567	519	421	547
	14.2%	12.9%	12.4%	10.2%	11.5%
	225	225	142	−138	−18.9
	—	190	99.5	130	—
	₹14.24	₹14.24	₹9.01	−₹8.76	−₹1.20
	42.43×	—	—	—	—
	—	1.89×	2.02×	2.35×	1.50×
	—	103	79.6	46.0	77.4
	—	63.1	73.6	67.9	44.0

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

JUBLINGREA₹604.00

Jubilant Ingrevia Ltd.

· Chemicals

₹ CrorePeersVIDHIING PARADEEP PCBL FACT OAL IGPL PAUSHAKLTD TIRUMALCHMMcap ₹9,543 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	122.2	136.2	157.6	175.5	—
+ Finance Costs	21.6	52.7	55.6	49.1	—
+ Interest Income	-1.2	-1.0	-2.9	-1.5	—
+ Share-based Payments	2.7	6.7	12.1	10.7	—
+ Unrealised FX (Gain) / Loss	1.2	0.6	-1.8	8.3	—
+ Other Non-cash Items	1.4	6.4	0.5	1.0	—
+ Other — Cash Effects are Investing / Financing	-0.1	0.0	0.0	0.0	—
+ Other Reconciling Items	0.5	1.0	0.0	-0.2	—
Changes in Working Capital
+ Inventories	-125.8	93.0	-2.1	65.0	—
+ Trade Receivables — Current	0.0	-62.1	-36.8	-168.1	—
+ Trade Receivables — Non-current	114.0	0.0	0.0	0.0	—
+ Other Financial Assets — Current	0.0	7.1	0.0	0.0	—
+ Other Financial Assets — Non-current	0.0	0.0	-0.7	-8.1	—
+ Trade Payables — Current	-33.3	-34.5	48.6	107.4	—
+ Other Financial Liabilities — Current	0.0	0.0	0.0	17.8	—
+ Other Current Liabilities	0.0	2.3	13.7	0.0	—
+ Provisions — Current	0.0	0.0	0.0	0.8	—
Cash from Operating Activities
Profit Before Tax (per I/S)	436.7	267.6	343.6	369.9	466.1
+ Total Adjustments (incl. Working Capital)	103.1	208.4	244.0	257.7	—
Cash from Operations (pre-tax)	539.8	476.0	587.7	627.6	—
+ Income Taxes Paid	77.4	46.0	79.6	103.3	—
Cash from Operating Activities	462.5	430.0	508.1	524.3	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	481.4	568.4	365.8	299.4	—
+ Disp of Fixed Assets	0.0	2.2	13.6	9.8	—
+ Disp of Investment Property	3.2	0.0	0.0	0.0	—
+ Purchase of Investments (Equity / Debt)	2.1	2.7	10.3	13.5	—
+ Acq of Subsidiaries / Businesses (net)	0.0	0.0	0.0	11.3	—
+ Interest Received — Investing	1.1	0.7	3.2	0.9	—
+ Other Inflows / (Outflows) — Investing	7.3	-0.7	-33.6	37.5	—
Cash from Investing Activities	-471.9	-568.8	-392.8	-275.9	—
Cash from Financing Activities
+ Proceeds from Exercise of Stock Options	0.0	0.0	4.4	2.1	—
+ Buyback / Redemption of Own Shares	0.0	0.0	0.0	32.2	—
+ Proceeds from Borrowings	267.7	336.3	48.0	109.9	—
+ Repayment of Borrowings	100.0	0.0	24.4	89.4	—
+ Payment of Lease Liabilities	2.8	2.7	3.3	3.6	—
+ Interest Paid	44.0	67.9	73.6	63.1	—
+ Dividends Paid	79.3	78.6	79.8	79.3	—
+ Other Inflows / (Outflows) — Financing	0.0	-42.9	0.0	0.0	—
Cash from Financing Activities	41.6	144.1	-128.8	-155.5	—
Net Changes in Cash (pre-FX)	32.2	5.3	-13.5	92.9	—
+ Effect of FX Rate Changes on Cash	3.0	0.7	4.1	26.2	—
Net Changes in Cash	35.1	6.1	-9.4	119.0	—
Closing Cash	72.7	78.8	69.4	—	—
Reference Items
EBITDA	547.1	421.1	519.1	567.0	700.7
EBITDA Margin %	11.46	10.18	12.43	12.92	14.23
Free Cash Flow (CFO − Capex)	-18.9	-138.4	142.3	224.9	224.9
Free Cash Flow to Equity	—	130.0	99.5	189.8	—
Free Cash Flow per Basic Share	-1.20	-8.76	9.01	14.24	14.24
Price to Free Cash Flow	—	—	—	—	42.43
Cash Flow to Net Income	1.50	2.35	2.02	1.89	—
Cash Paid for Taxes	77.4	46.0	79.6	103.3	—
Cash Paid for Interest	44.0	67.9	73.6	63.1	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.